LCGC
GILD icon

Legacy Capital Group California’s Gilead Sciences GILD Stock Holding History

Legacy Capital Group California’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$580K Sell
4,159
-1,704
-29% -$239K 0.22% 156
2025
Q4 		$720K Sell
5,863
-6
-0.1% -$729 0.17% 157
2025
Q3 		$651K Buy
5,869
+40
+0.7% +$4.55K 0.17% 166
2025
Q2 		$646K Sell
5,829
-138
-2% -$14.7K 0.18% 146
2025
Q1 		$669K Sell
5,967
-60
-1% -$6.19K 0.23% 117
2024
Q4 		$557K Sell
6,027
-35
-0.6% -$3.15K 0.17% 160
2024
Q3 		$508K Sell
6,062
-412
-6% -$31.4K 0.17% 170
2024
Q2 		$444K Buy
6,474
+67
+1% +$4.47K 0.16% 181
2024
Q1 		$469K Sell
6,407
-127
-2% -$9.77K 0.17% 176
2023
Q4 		$529K Sell
6,534
-80
-1% -$6.22K 0.2% 150
2023
Q3 		$496K Buy
6,614
+14
+0.2% +$1.08K 0.21% 141
2023
Q2 		$509K Buy
6,600
+191
+3% +$15.2K 0.21% 150
2023
Q1 		$532K Buy
+6,409
New +$531K 0.26% 115

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Legacy Capital Group California's GILD Position: Q1 2026 in Review

Legacy Capital Group California reduced its Gilead Sciences (GILD) stake by 29% in Q1 2026, selling an estimated $239K and leaving 4,159 shares worth $580K. The position accounts for 0.22% of the portfolio, ranked #156.

Legacy Capital Group California first reported a position in GILD in Q1 2023 and has held it in 13 quarters since. The position peaked at $720K in Q4 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Legacy Capital Group California held 4,159 shares of Gilead Sciences worth $580K as of Q1 2026.
  • Legacy Capital Group California sold 1,704 Gilead Sciences shares in Q1 2026, an estimated $239K.
  • Gilead Sciences made up 0.22% of Legacy Capital Group California's portfolio in Q1 2026, its #156 holding.
  • Legacy Capital Group California first reported a position in Gilead Sciences in Q1 2023 and has held it in 13 quarters since.
  • Legacy Capital Group California's Gilead Sciences position peaked at $720K in Q4 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.